Posts

Diversity in all clinical research—including rare disease research—is currently under scrutiny, partly because of disparities experienced with COVID-19. Rightly so, as data show that 86 percent of genomics studies to date have involved people of European ancestry, which has limited the potential benefits of genomic research for many populations. Rebecca Sutphen, Co-Founder and Chief Medical Officer of InformedDNA, and Board-Certified Genetic Counselor Karmen Trzupek analyze strategies to increase diversity in rare genetic disease trials.

As the Manny Awards returned to an in-person event in April 2022 for the first time in three years because of the COVID-19 pandemic, many of the healthcare communications agencies and networks featured in Med Ad News’ annual special report are thriving.